c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Vor Biopharma (VOR) Expands RC298 Licensing Deal with RemeGen, Valued up to $356M
GuruFocus | Nov 12, 2026 1:58 PM EST
Related Stocks: VOR ,
Read original article